Rejuvenate Bio Investor Webinar
We’re excited by the growing interest in Rejuvenate Bio's mission and progress, and we invite you to join us for an exclusive investor webinar with Rejuvenate Bio’s leadership team.
During the session, Co-Founders Daniel Oliver (CEO) and Noah Davidsohn, PhD (CSO) will walk through our scientific platforms, recent commercial and regulatory traction, and how our animal health programs are funding a scalable path into human clinical development.
We’ll cover:
Our dual-platform approach spanning animal and human health
Key partnerships, milestones, and near-term inflection points
How one-time gene therapies can redefine treatment for chronic and age-related diseases
How you can become a shareholder at this early stage
We’ll conclude with a live Q&A and answer your questions in real time.
We look forward to sharing more and connecting with you! In the meantime, you can review our investment offering and reserve your early bird terms at https://wefunder.com/rejuvenatebio/.